Teva Pharmaceutical IndTEVA
13F holders, Q3 2025 (September 30)1holders
0new positions
0sold out
$20.20avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Teva Pharmaceutical Ind Ltd. (TEVA) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holder was Old Mission Capital LLC ($638K).
- Company
- Teva Pharmaceutical Ind Ltd.
- CUSIP
- M8769Q102
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 12,729 shares sold, net −12,729 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Old Mission Capital LLC | 0.02% | Reduce -28.7% | 31,565 | $638K |
"% of holder's portfolio" is TEVA's weight in each manager's 13F, not the share of Teva Pharmaceutical Ind Ltd. the manager owns.